Àurea Navarro-Sabaté

4PUBLICATIONS
25CO-AUTHORS
Epidemiological methodsCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jan 25, 2025
Evaluating the Quality of Real-World Data on Adherence to Oral Endocrine Therapy in Breast Cancer Patients: How Real Is Real-World Data?

A Navarro-Sabaté, R Font, J A Espinàs

|Jan 26, 2024
The Impact of the COVID-19 Pandemic on Adherence to Endocrine Therapy for Breast Cancer in Catalonia (Spain).

Aurea Navarro-Sabate, Rebeca Font, Fina Martínez-Soler

|Nov 19, 2022
BRAF activation by metabolic stress promotes glycolysis sensitizing NRAS<sup>Q61</sup>-mutated melanomas to targeted therapy.

Kimberley McGrail, Paula Granado-Martínez, Rosaura Esteve-Puig

|Feb 15, 2022
The Expression of TP53-Induced Glycolysis and Apoptosis Regulator (TIGAR) Can Be Controlled by the Antioxidant Orchestrator NRF2 in Human Carcinoma Cells.

Helga Simon-Molas, Cristina Sánchez-de-Diego, Àurea Navarro-Sabaté

Pageof 1

Frequent Collaborators

2 joint publications

Fina Martínez-Soler

2 joint publications

Anna Manzano

1 joint publications

J A Espinàs

1 joint publications

M Gil-Gil